XENE

XENON PHARMACEUTICALS INC

Healthcare | Mid Cap

-$1.18

EPS Forecast

$13.5

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$1.18

Revenue Forecast:

$13.5

EPS Surprise Forecast:

$0.000

Revenue Surprise Forecast:

-$2

Post-release price volatility - Medium

Post-release Overnight Move:

±6.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

53%

Probability of beating revenue consensus:

47%

Probability of beating both EPS & revs consensus:

31%

Probability of missing both EPS & revs consensus:

31%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

1.80

Earnings volatility

EPS standard deviation:

$0.20

Revenue standard deviation:

$24

As % of share price:

0.36% MEDIUM

As % of market cap:

0.53% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.92

Revenue 95th %ile:

$46

EPS 75th %ile:

-$1.11

Revenue 75th %ile:

$22

EPS 25th %ile:

-$1.23

Revenue 25th %ile:

$6

EPS 5th %ile:

-$1.39

Revenue 5th %ile:

-$13

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

25% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$20

Bid-ask per Share:

$0.11